Cargando…
Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta‐analysis
Enhancer of zeste 2 (EZH2), a key component of polycomb repressive complex 2 (PRC2), was of great importance in human cancer pathogenesis. Various studies examined the relationship between EZH2 overexpression with the clinical outcome in patients with digestive cancers, but yielded conflicting resul...
Autores principales: | Wang, Yawei, Gao, Fang, Zhao, Meng, Li, Bing, Xing, Dan, Wang, Jie, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831352/ https://www.ncbi.nlm.nih.gov/pubmed/26859127 http://dx.doi.org/10.1111/jcmm.12791 |
Ejemplares similares
-
The clinicopathological and prognostic significances of EZH2 expression in urological cancers: A meta‑analysis and bioinformatics analysis
por: Bai, Yang-Kai, et al.
Publicado: (2023) -
Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis
por: Wang, Xinhua, et al.
Publicado: (2016) -
Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma
por: Xing, Hui, et al.
Publicado: (2022) -
The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review
por: Wang, Yawei, et al.
Publicado: (2016) -
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis
por: Fang, Pinhao, et al.
Publicado: (2022)